Primary Site >> Liver Cancer
Gene >> EGFL7
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|
|
Ref: Novel role for epidermal growth factor-like domain 7 in metastasis of human hepatocellular carcinoma. PMID: 19824075 |
Ref: Down-regulation of EGFL8: a novel prognostic biomarker for patients with colorectal cancer. PMID: 21737648 |
Ref: Human anti-EGFL7 recombinant full-length antibodies selected from a mammalian cell-based antibody display library. PMID: 22297616 |
Ref: The expression of Egfl7 in human normal tissues and epithelial tumors. PMID: 23558933 |
Ref: Targeting EGFL7 expression through RNA interference suppresses renal cell carcinoma growth by inhibiting angiogenesis. PMID: 24815445 Ref: Real-time immuno-polymerase chain reaction in a 384-well format: detection of vascular endothelial growth factor and epidermal growth factor-like domain 7. PMID: 25013989 |
Ref: Multivariate analysis of molecular markers in peripheral blood associated with recurrence and metastasis of hepatocellular carcinoma. PMID: 25730089 Ref: Expression of epidermal growth factor-like domain 7 is increased by transcatheter arterial embolization of liver tumors. PMID: 25735354 |
Ref: Different expression of VEGF and EGFL7 in human hepatocellular carcinoma. PMID: 26542361 Ref: MicroRNA-126 inhibits tumor proliferation and angiogenesis of hepatocellular carcinoma by down-regulating EGFL7 expression. PMID: 27611944 |
Ref: Effects of microRNA-126 on cell proliferation, apoptosis and tumor angiogenesis via the down-regulating ERK signaling pathway by targeting EGFL7 in hepatocellular carcinoma. PMID: 28881749 |
Ref: EGFL7: Master regulator of cancer pathogenesis, angiogenesis and an emerging mediator of bone homeostasis. PMID: 29923200 Ref: Increased expression of epidermal growth factor-like domain-containing protein 7 is predictive of poor prognosis in patients with hepatocellular carcinoma. PMID: 29970668 Ref: EGFL7 promotes hepatocellular carcinoma cell proliferation and inhibits cell apoptosis through increasing CKS2 expression by activating Wnt/beta-catenin signaling. PMID: 30129142 |